Browsing publications by Professor Ruth Plummer

Newcastle AuthorsTitleYearFull text
Professor Ruth Plummer
A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers2017
Professor Ruth Plummer
Adjuvant Dabrafenib plus Trametinib in stage III BRAF-mutated melanoma2017
Amy Cranston
Dr Deborah Stocken
Elaine Stamp
Professor Ruth Plummer
Professor Sir John Burn
et al.
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.2017
Dr Neil Rajan
Dr Thomas Oliphant
Professor Ruth Plummer
Dr James Langtry
Advanced basal cell carcinomas treated by vismodegib and Mohs micrographic surgery: does neoadjuvant treatment have a role?2016
Professor Ruth Plummer
Professor Steve Wedge
Clinical development of new drug-radiotherapy combinations2016
Dr Rachel Pearson
Dr Peter Thelwall
Jim Snell
Jill McKenna
Dr Piotr Pieniazek
et al.
Evaluation of early response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using dynamic contrast-enhanced MRI and diffusion weighted MRI: MARBLE study2016
Dr Rachel Pearson
Dr Peter Thelwall
Jim Snell
Dr Piotr Pieniazek
Dr Rakesh Heer
et al.
Evaluation of early responses to neoadjuvant chemotherapy in muscle-invasive bladder cancer using a dynamic contrast-enhanced MRI and diffusion-weighted MRI: MARBLE study2016
Barry Dent
Laura Ogle
Dr Rachel O'Donnell
Dr Ujjal Mallick
Professor Nicola Curtin
et al.
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers2016
Laura Ogle
Dr James Orr
Catherine Willoughby
Dr Claire Hutton
Dr Stuart McPherson
et al.
Imagestream detection and characterisation of circulating tumour cells - a liquid biopsy for Hepatocellular Carcinoma?2016
Professor Ruth Plummer
Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis2016
123456789101112131415